Kathy Pritchard-Jones
UCL Institute of Child Health
331 Papers
2.3K Citations
Kathy Pritchard-Jones is an academic researcher from UCL Institute of Child Health. The author has contributed to research in topics: Wilms' tumor & Medicine. The author has an hindex of 63, co-authored 306 publications. Previous affiliations of Kathy Pritchard-Jones include Royal Alexandra Children's Hospital & National Institute for Health Research.
Chat about Author
Papers
Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour
Sandra Hanks,Elizabeth R Perdeaux,Sheila Seal,Elise Ruark,Shazia Mahamdallie,Anne Murray,Emma Ramsay,Silvana Del Vecchio Duarte,Anna Zachariou,Bianca de Souza,Margaret Warren-Perry,Anna Elliott,Alan Davidson,Helen Price,Charles A. Stiller,Kathy Pritchard-Jones,Nazneen Rahman +16 more
TL;DR: Inactivating CTR9 mutations in 3 of 35 Wilms tumour families are identified and these data establish CTR9 as a Wilms cancer predisposition gene and suggest it acts as a tumour suppressor gene.
Nephron Sparing Surgery (NSS) for Unilateral Wilms Tumor (UWT): The SIOP 2001 Experience
Jim C. H. Wilde,Daniel C. Aronson,Beata Sznajder,Harm van Tinteren,Mark Powis,Bruce Okoye,Giovanni Cecchetto,Georges Audry,Joerg Fuchs,Dietrich von Schweinitz,Hugo A. Heij,Norbert Graf,Christophe Bergeron,Kathy Pritchard-Jones,Marry M. van den Heuvel-Eibrink,Modesto Carli,Foppe Oldenburger,Bengt Sandstedt,Jan de Kraker,Jan Godzinski +19 more
TL;DR: Inventory of the current SIOP NSS‐experience for polar or peripherally non‐infiltrating tumors for Nephron Sparing surgery for unilateral Wilms tumors.
103
TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse Anaplasia
Mariana Maschietto,Richard D. Williams,Tasnim Chagtai,Sergey Popov,Neil J. Sebire,Gordan M. Vujanic,Elizabeth J. Perlman,James R. Anderson,Paul E. Grundy,Jeffrey S. Dome,Kathy Pritchard-Jones +10 more
TL;DR: Evidence is provided that TP53 mutational analysis improves risk stratification in DAWT, and this requires validation in an independent cohort before clinical use as a biomarker.
Childhood cancer incidence and survival in Japan and England: A population-based study (1993-2010).
Kayo Nakata,Kayo Nakata,Yuri Ito,Winnie Magadi,Audrey Bonaventure,Charles A. Stiller,Kota Katanoda,Tomohiro Matsuda,Isao Miyashiro,Kathy Pritchard-Jones,Bernard Rachet +10 more
TL;DR: There were significant differences in incidence of several cancers between countries, suggesting variation in genetic susceptibility and possibly environmental factors, and 5‐year survival improved in both countries.
95
Predisposition to cancer in children and adolescents.
Christian P. Kratz,Marjolijn C.J. Jongmans,Hélène Cavé,Katharina Wimmer,Sam Behjati,Léa Guerrini-Rousseau,Till Milde,Kristian W. Pajtler,Kristian W. Pajtler,Lisa Golmard,Marion Gauthier-Villars,Rosalyn Jewell,Catriona Duncan,Eamonn R. Maher,Laurence Brugières,Kathy Pritchard-Jones,Franck Bourdeaut +16 more
TL;DR: A recent review as mentioned in this paper summarizes the current knowledge and defines future research needs in this evolving field and provides management recommendations for individuals with pathogenic germline variants in cancer predisposition genes.
92